Navigation Links
China Interventional Cardiovascular Device Industry Report, 2014-2017
Date:5/27/2015

NEW YORK, May 27, 2015 /PRNewswire/ -- The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing year after year, thereby promoting the development of domestic percutaneous coronary intervention (PCI) market. PCI cases in China totaled 454,505 in 2013, up 16.9% from a year earlier; meanwhile the interventional cardiovascular device industry there was worth RMB20.12 billion.

At present, half of the Chinese interventional cardiovascular device industry is dominated by domestic companies led by MicroPort, Lepu Medical, Lifetech Scientific, and Dalian Yinyi. In 2013, 53.4% of the Chinese market was controlled by domestic companies, 31.2% by foreign counterparts represented by Johnson & Johnson, Medtronic, Boston Scientific, Abbott, B. Braun and Terumo, and 15.4% by those invested by Hong Kong, Macao and Taiwan.

Interventional cardiovascular devices in China include cardiovascular stent, catheter, guidewire, balloon, surgical auxiliary devices, etc., among which cardiovascular stent is predominant.

Cardiovascular stent: In 2013, the Chinese cardiovascular stent market equaled RMB11.2 billion, 78.8% of which was occupied by domestic drug-eluting stents. That same year, 686,000 units of cardiovascular stent were consumed in China, up 11.7% year on year, and drug-eluting stents accounted for 99.5%, indicating that the drug-eluting stent is gradually becoming an important device for interventional cardiovascular therapy.

In addition, Abbott has developed biodegradable stents, which are sold in Europe; Lepu Medical is endeavoring to develop biodegradable stents, which are expected to be available on the market in 2017. Thanks to its excellent performance, biodegradable stents are likely to replace drug-eluting stents gradually in the future, thus becoming the main variety in domestic coronary stent market.

Balloon catheter: In 2013, China's demand for PTCA balloon catheter amounted to 1.186 million units, 500,000 of which were PTCA balloon catheters for dilatation. With rapid development of local PTCA balloon catheter producers represented by Lepu Medical, MicroPort and JW Medical, domestic PTCA balloon catheters increased its market share from 20% in 2009 to 40% in 2013.

Affected by the implementation of "Regulations on the Centralized Procurement of High-value Medical Consumables", purchase price of interventional cardiovascular devices will continue to decline, further squeezing profit margins of relevant companies. However, the substantial decline in prices will enable more patients to receive PCI, thus helping the industry maintain a fairly rapid growth rate. It is expected that the Chinese interventional cardiovascular device market will worth RMB41.2 billion by 2017.

China Interventional Cardiovascular Device Industry Report, 2014-2017 focuses on the following:

Status quo of China interventional cardiovascular device industry, including overview, market demand, import & export, competitive landscape and entry barriers;
Development environment of China interventional cardiovascular device industry, embracing macro environment, policy climate and upstream & downstream sectors;
Status quo, competitive landscape, etc. of China interventional cardiovascular device market segments, covering coronary stent, balloon catheter, catheter, guidewire, sheath group and auxiliary devices;
Operation, interventional cardiovascular device business, etc. of 6 foreign and 12 Chinese interventional cardiovascular device companies.
Read the full report: http://www.reportlinker.com/p0370585-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001


'/>"/>
SOURCE Reportlinker
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. RuiYi and Genor BioPharma Collaborate on Development in China of RYI-008, a Novel Therapeutic for Autoimmune Diseases and Cancer
2. Hemp, Inc. Signs Letter of Intent with One of Chinas Largest Agricultural Producers, Yasheng Group
3. China Pharmaceutical Market Guidebook Series (4) 2013 Report
4. Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines
5. China Biologic Comments on the Proposed Shanghai RAAS Transaction
6. China Nepstar Chain Drugstore Ltd. Announces Appointment of New Director
7. China Nepstar Chain Drugstore Ltd. Reports First Quarter 2013 Financial Results
8. iBio Obtains New IP Protection in China
9. China & North East Asia Medical Device Market Reports
10. China Biologic Updates the Hong Kong Litigation in respect of the Shares Held by Ms. Siu Ling Chan
11. OrthoTec China 2013 is Coming Up Soon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2020)... ... February 20, 2020 , ... Amada Senior Care of ... senior care from trained and knowledgeable Amada caregivers. From day one of opening, ... every client’s unique needs, preferences and desires, all with the goal of delivering ...
(Date:2/20/2020)... ... 20, 2020 , ... PAINWeekEnd on March 21 and 22 ... a timely and relevant 2-day program providing busy clinicians and allied healthcare practitioners ... , In 2020, paper prescriptions for certain painkillers have been banned in Arizona. ...
(Date:2/19/2020)... ... ... Aspire Regenerative, a leader in offering therapies that restore healthy tissues in ... event on March 1, 2020. It will take place from 10:30 a.m. to 1:30 ... the event, physicians and pharmacists will lead an informative and insightful discussion on weight ...
Breaking Medicine Technology:
(Date:2/20/2020)... ... February 20, 2020 , ... Millennial women are flocking to cosmetic surgeons like ... Penn requesting treatments to achieve “ Rich Girl Face .” In fact, Glamour magazine ... slowing down into 2020. It’s a look inspired by the signature bee-stung lips, smooth ...
(Date:2/19/2020)... (PRWEB) , ... February 19, 2020 , ... ... the film industry. While he is most known for his acting abilities demonstrated ... host on the educational show “Behind The Scenes” with Laurence Fishburne. “Behind The ...
(Date:2/19/2020)... ... February 19, 2020 , ... SEAL SHIELD, LLC - Almost a ... healthcare-acquired infections (HAIs.) According to The Centers for Disease Control (CDC), 80% of infections ... of screens that are now acting as an extension of people’s hands, but not ...
(Date:2/15/2020)... Calif. (PRWEB) , ... February 14, 2020 , ... Sister ... webinar series - “BIG MONEY IN ABA”. The series explores the challenges, risks, ... next webinar in the series on March 25, 2020 at: https://bit.ly/2OU6lxg ...
(Date:2/14/2020)... MILFORD, Pa. (PRWEB) , ... February 14, 2020 ... ... that consumers were most bothered by excess weight, skin texture and discoloration, and ... sculpting, skin tightening and injectables. MilfordMD is offering some great specials in February ...
Breaking Medicine News(10 mins):